1. 1Hematology Laboratory, Unité 1277-Cancer Heterogeneity Plasticity and Resistance to Therapies (CANTHER), Centre Hospitalier Universitaire (CHU) de Lille, University of Lille, INSERM, Lille, France;
2. 2Hematology Laboratory, CHU de Toulouse–Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France;
3. 3Université de Paris, Unité 944/7212-GenCellDi, INSERM and Centre National de la Recherche Scientifique (CNRS), Paris, France;
4. 4Hematology Laboratory, Saint Louis Hospital, Assistance Publique–Hôpitaux de Paris (AP-HP), Paris, France;
5. 5Hematology Department, Versailles Hospital, Le Chesnay, France;
6. 6Hematology Laboratory, CHU de Bordeaux, Bordeaux, France;
7. 7Hematology Department, Saint Louis Hospital, AP-HP, Paris, France;
8. 8Sorbonne Université, INSERM, Centre de Recherche Saint-Antoine, CRSA, AP-HP, Laboratoire d’hématologie biologique, Hôpital Saint-Antoine, Paris, France;
9. 9Hematology Laboratory, Cochin Hospital, AP-HP, Paris, France;
10. 10Hematology Department, Cochin Hospital, AP-HP, Paris, France;
11. 11Hematology Laboratory, CHU Angers, Angers, France;
12. 12Hematology Biology, Nantes University Hospital, Nantes, France;
13. 13CRCINA, INSERM, CNRS, Université de Nantes, Université d'Angers, Nantes, France;
14. 14Hematology Department, CHU Orléans, Orléans, France;
15. 15Hematology Department, CHU Troyes, Troyes, France;
16. 16Hematology Department, Hospices Civils de Lyon, Lyon-Sud Hospital, Lyon, France;
17. 17Hematology Department, Gustave Roussy Institute, University of Paris-Saclay, Villejuif, France;
18. 18Hematology Department, Avicenne Hospital, AP-HP, Bobigny, France;
19. 19Unité 3518, Saint-Louis Institute for Research, Université de Paris, Paris, France;
20. 20Service d'Hématologie, Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse Oncopole, Université Toulouse III Paul Sabatier, Toulouse, France; and
21. 21Hematology Department, CHU de Bordeaux, Bordeaux, France